Position in RPRX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$26,632,633
+$25,064,878 QoQ
Shares Held
474,989
+1353.4% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#6
of 107 holders
Holding Since
Mar 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Achmea Investment Management B.V. holds $26,632,633 across 1 Biotechnology name. RPRX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
474,989 | $26,632,633 |
All Filings in RPRX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,632,633 | 474,989 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $1,567,755 | 32,682 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,321,217 | 34,193 | Shares | Defined | 2026-02-18 | |
| 2025-06-30 | $1,231,973 | 34,193 | Shares | Defined | 2025-08-06 | |
| 2023-06-30 | $602,042 | 19,585 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $705,647 | 19,585 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $1,547,998 | 39,170 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $786,925 | 19,585 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $20,641 | 491 | Shares | Defined | 2022-08-10 | |
| 2021-09-30 | $17,744 | 491 | Shares | Defined | 2021-11-12 | |
| 2021-03-31 | $1,172,985 | 26,891 | Shares | Defined | 2021-05-11 | |
| No filing history on record for this holder in this stock. | ||||||